Corvus Pharmaceuticals, Inc.

ORBIMED ADVISORS LLC CRVS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

7,165,006

Value ($000)

55,171

Weight

1.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	55,171	1.1%	7,165,006	12/31/2025
2025 Q3	11/14/2025	52,806	1.3%	7,165,006	9/30/2025
2025 Q2	8/14/2025	28,660	0.7%	7,165,006	6/30/2025
2025 Q1	5/15/2025	22,081	0.5%	6,943,654	3/31/2025
2024 Q4	2/14/2025	37,149	0.8%	6,943,654	12/31/2024
2024 Q3	11/14/2024	36,662	0.7%	6,943,654	9/30/2024
2024 Q2	8/14/2024	12,637	0.3%	6,943,654	6/30/2024
2024 Q1	5/15/2024	12,360	0.2%	6,943,654	3/31/2024
2023 Q4	2/14/2024	12,221	0.2%	6,943,654	12/31/2023
2023 Q3	11/14/2023	10,138	0.2%	6,943,654	9/30/2023
2023 Q2	8/14/2023	15,901	0.3%	6,943,654	6/30/2023
2023 Q1	5/15/2023	6,319	0.1%	6,943,654	3/31/2023
2022 Q4	2/14/2023	5,902	0.1%	6,943,654	12/31/2022
2022 Q3	11/14/2022	5,683	0.1%	6,943,654	9/30/2022
2022 Q2	8/15/2022	6,875	0.1%	6,943,654	6/30/2022
2022 Q1	5/16/2022	11,388	0.2%	6,943,654	3/31/2022
2021 Q4	2/14/2022	16,734	0.2%	6,943,654	12/31/2021
2021 Q3	11/15/2021	33,607	0.4%	6,943,654	9/30/2021
2021 Q2	8/16/2021	21,502	0.2%	8,053,298	6/30/2021
2021 Q1	5/17/2021	24,804	0.2%	8,053,298	3/31/2021
2020 Q4	2/16/2021	24,093	0.2%	6,767,584	12/31/2020
2020 Q3	11/16/2020	27,138	0.3%	6,767,584	9/30/2020
2020 Q2	8/14/2020	18,408	0.3%	6,767,584	6/30/2020
2020 Q1	5/15/2020	14,280	0.2%	6,767,584	3/31/2020
2019 Q4	2/14/2020	36,816	0.5%	6,767,584	12/31/2019